Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeladon Pharmaceuticals Regulatory News (CEL)

  • This share is currently suspended. It was suspended at a price of 13.40
  • There is currently no data for CEL

Annual Report and Accounts

7 Jul 2006 16:53

Celsis International PLC07 July 2006 CELSIS INTERNATIONAL PLC 7 July 2006: Celsis International plc (the 'Company'), the rapid diagnostics andanalytical services company, today announces that a copy of the followingdocuments have been submitted to the UK Listing Authority, and will shortly beavailable for inspection at the UK Listing Authority's Document ViewingFacility, which is situated at the Financial Services Authority, 25 The NorthColonnade, Canary Wharf, London E14 5HS, telephone no. 020 7066 1000. Annual Report and Accounts for the year ended 2006Notice of Annual General Meeting 2006Form of Proxy for the 2006 Annual General Meeting Enquiries: Celsis International plc Tel: 01638 600 151Christian Madrolle, Finance Director & Company SecretaryJenny Parsons, Corporate Communications Financial Dynamics Tel: 020 7831 3113Ben AtwellAnna Keeble Notes to editors Celsis International plc Celsis International plc is a rapid diagnostics and analytical services company. The company is listed on the London Stock Exchange (CEL.L). Using proprietary technology, the Product Group is the world leader in theprovision of diagnostic systems for the rapid detection of microbialcontamination. It works in close collaboration with many of the world's leadingpharmaceutical, personal care and beverage companies, ensuring the safety andquality of products bound for consumers. The Laboratory Group providesoutsourced analytical testing services to pharmaceutical and biopharmaceuticalcompanies to ensure the stability and chemical composition of their products. In addition to ensuring product quality and safety for consumers, both divisionshave the capacity to deliver substantial cost savings to Celsis' customers. Byreducing the time it takes to test and release raw materials and finished goodsto the market place, Celsis' products facilitate increased manufacturingproductivity and improved supply chain management. Further information can be found on its website at www.celsis.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Jun 20235:30 pmRNSResult of AGM
5th Jun 20232:46 pmRNSPublication of Annual Report and Notice of AGM
5th Jun 20237:00 amRNSFinal Results for the year ended 31 December 2022
30th May 20237:00 amRNS£7 Million Committed Credit Facility
26th May 20237:00 amRNSNotice of Results and Investor Presentation
25th May 20237:00 amRNSWest Midlands Mayor Visits Celadon’s Facility
24th May 20237:00 amRNSInaugural Supply Contract Win
29th Mar 202311:05 amRNSSecond Price Monitoring Extn
29th Mar 202311:00 amRNSPrice Monitoring Extension
17th Mar 20234:35 pmRNSPrice Monitoring Extension
17th Mar 20232:05 pmRNSSecond Price Monitoring Extn
17th Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 20233:01 pmRNSSuccessful Update to Home Office Licence
14th Mar 20232:05 pmRNSSecond Price Monitoring Extn
14th Mar 20232:00 pmRNSPrice Monitoring Extension
13th Mar 20234:40 pmRNSSecond Price Monitoring Extn
13th Mar 20234:35 pmRNSPrice Monitoring Extension
13th Mar 20239:05 amRNSSecond Price Monitoring Extn
13th Mar 20239:00 amRNSPrice Monitoring Extension
10th Mar 20234:40 pmRNSSecond Price Monitoring Extn
10th Mar 20234:35 pmRNSPrice Monitoring Extension
10th Mar 20232:05 pmRNSSecond Price Monitoring Extn
10th Mar 20232:00 pmRNSPrice Monitoring Extension
10th Feb 20232:15 pmRNSNotification of transaction by PDMR
19th Jan 20237:00 amRNSChange of Website Address
16th Jan 20237:00 amRNSApproval of GMP Registration by MHRA
13th Jan 20237:00 amRNSUpdate on CFO Appointment
30th Dec 20227:00 amRNSResults of Feasibility Study
22nd Dec 20227:00 amRNSUpdate on GMP Registration by MHRA
1st Nov 20227:00 amRNSAppointment of CFO
29th Sep 20227:00 amRNSInterim Report for six months ended 30 June 2022
12th Sep 20227:00 amRNSNotice of Results
28th Jul 20227:00 amRNSAppointment of Tessera Investment Management
27th Jun 20226:15 pmRNSResult of AGM
22nd Jun 20227:00 amRNSBusiness Update
31st May 20221:30 pmRNSNotice of AGM
29th Apr 20227:00 amRNSFull year results
29th Apr 20227:00 amRNSFull year results
31st Mar 20228:08 amRNSHolding(s) in Company
30th Mar 20224:41 pmRNSSecond Price Monitoring Extn
30th Mar 20224:36 pmRNSPrice Monitoring Extension
29th Mar 20228:00 amRNSChange of Name
7th Oct 20099:56 amRNSHolding(s) in Company
1st Oct 20096:29 pmRNSTransfers from Treasury and Admission of Shares
30th Sep 200910:50 amRNSHolding(s) in Company
24th Sep 20097:00 amRNSClosing of the Offer
9th Sep 20094:26 pmRNSCancellation of Listing
9th Sep 200912:56 pmRNSOffer Update
4th Sep 200911:57 amRNSDirector Declaration
3rd Sep 20097:00 amRNSOffer Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.